ProQR Therapeutics BV Dividends
The next dividend date for ProQR Therapeutics BV has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for ProQR Therapeutics BV (PRQR)
More About ProQR Therapeutics BV
ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company's products pipeline includes AX-0810 for cholestatic diseases targeting Na-taurocholate cotransporting polypeptide (NTCP); and AX-1412 for cardiovascular diseases (CVDs) targeting Beta-1,4-galactosyltransferase 1 (B4GALT1). It also develops various other early-stage research programs, including AX-1005 for undisclosed targets in CVDs; AX-2402, which focuses on Rett syndrome; AX-2911 for metabolic dysfunction-associated steatohepatitis (MASH) targeting patatin-like phospholipase domain-containing protein 3 (PNPLA3); AX-0601 for obesity and Type 2 diabetes; and AX-9115 for rare metabolic condition, as well as additional programs in Rett Syndrome, additional CNS programs, and multiple other unnamed targets and programs. In addition, the company develops Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center; Inserm Transfert SA; Ionis Pharmaceuticals, Inc.; Vico Therapeutics B.V.; University of Rochester; and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The company was incorporated in 2012 and is headquartered in Leiden, the Netherlands.
Owning ProQR Therapeutics BV Stock on the Dividend Date
If you own ProQR Therapeutics BV stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of ProQR Therapeutics BV stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of ProQR Therapeutics BV stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying ProQR Therapeutics BV stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the ProQR Therapeutics BV dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More ProQR Therapeutics BV Dividends
You can contact us any time if you would like to ask questions about ProQR Therapeutics BV dividends or anything else related to the stock market.